🔎 Trials Near Me

Home › Overweight › California › Concord

Overweight clinical trials in Concord, CA

16 studies for Overweight are looking for participants at sites in and around Concord (within about 30 miles). Open a study to see who can join and how to contact the study team.

Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →

Safety and Efficacy of ABBV-295 in Adults With Obesity or Overweight With Weight-Related Comorbidities

RecruitingPhase 2
  • John Muir Health - Concord /ID# 282469, Concord
  • Diablo Clinical Research /ID# 282530, Walnut Creek · 5 mi away
Ages 18 to 75 · All sexes · Updated Oct 2, 2026 · NCT07752979

AMAZE 2: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Type 2 Diabetes Lose Weight

RecruitingPhase 3
  • Diablo Clinical Research, Inc., Walnut Creek · 5 mi away
Ages 18 and older · All sexes · Updated Sep 30, 2026 · NCT07533175

Study of Olatorepatide in Adult Participants Living With Overweight or Obesity Without Diabetes

RecruitingPhase 2
  • Diablo Clinical Research - Flourish Research, Walnut Creek · 5 mi away
Ages 18 and older · All sexes · Updated Sep 29, 2026 · NCT07685808

AMAZE 9: A Research Study Investigating How Well Zenagamtide Tablets Help People With Excess Body Weight Lose Weight

RecruitingPhase 3
  • Diablo Clinical Research, Inc., Walnut Creek · 5 mi away
Ages 18 and older · All sexes · Updated Sep 28, 2026 · NCT07720271

A Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 Obesity

RecruitingPhase 3
  • Diablo Clinical Research, Inc., Walnut Creek · 5 mi away
Ages 18 and older · All sexes · Updated Sep 28, 2026 · NCT07794579

A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity

RecruitingPhase 3
  • Diablo Clinical Research, Inc., Walnut Creek · 5 mi away
Ages 18 and older · All sexes · Updated Sep 28, 2026 · NCT07595549

A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes

RecruitingPhase 3
  • Diablo Clinical Research, Inc., Walnut Creek · 5 mi away
Ages 18 and older · All sexes · Updated Sep 22, 2026 · NCT07282600

A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight

RecruitingPhase 3
  • Research Site, Walnut Creek · 5 mi away
Ages 18 and older · All sexes · Updated Sep 22, 2026 · NCT07784270

Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity

RecruitingPhase 3
  • Diablo Clinical Research, Walnut Creek · 5 mi away
Ages 45 to 99 · All sexes · Updated Sep 22, 2026 · NCT07037433

Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or Overweight

RecruitingPhase 3
  • Diablo Clinical Research, Inc., Walnut Creek · 5 mi away
Ages 18 and older · All sexes · Updated Sep 22, 2026 · NCT07353931

A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight

RecruitingPhase 2
  • Diablo Clinical Research, Inc., Walnut Creek · 5 mi away
Ages 18 to 75 · All sexes · Updated Sep 22, 2026 · NCT07589608

A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes

RecruitingPhase 3
  • Diablo Clinical Research, Inc., Walnut Creek · 5 mi away
Ages 18 and older · All sexes · Updated Sep 14, 2026 · NCT07351045

A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight

RecruitingPhase 2
  • Diablo Clinical Research, Inc., Walnut Creek · 5 mi away
Ages 18 to 75 · All sexes · Updated Sep 8, 2026 · NCT06143956

Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)

RecruitingPhase 3
  • Diablo Clinical Research, Walnut Creek · 5 mi away
Ages 18 to 99 · All sexes · Updated Sep 3, 2026 · NCT07684235

Evaluation of the Tolerability of Cagrilintide in Participants Not Tolerating GLP-1-RA Therapies Due to Gastrointestinal Adverse Events

RecruitingPhase 1
  • Diablo Clinical Research, Inc., Walnut Creek · 5 mi away
Ages 18 and older · All sexes · Updated Jun 25, 2026 · NCT07607587

Overweight trials in other cities

Other studies in Concord

From ClinicalTrials.gov, data retrieved Oct 4, 2026. Each study sets its own eligibility; the study team decides who can join.